United Kingdom · Remote OK
$86k–$108k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Oncology, Medical Science Liaison, Clinical research, Drug development, Scientific communication
Switzerland · Remote OK
$163k–$203k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Oncology, Account Management, Strategic Planning, Business Acumen, Market Access
France · Remote OK
$119k–$148k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Medical Affairs, Oncology, Clinical Development, Scientific Exchange, Key Opinion Leader Management
Munich, Bavaria, Germany · Hybrid
$138k–$173k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Corporate law, Pharmaceutical law, Commercial law, Competition law, Healthcare compliance
United States · Hybrid
$201k–$251k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Global brand strategy, Oncology marketing, Commercialization, Launch readiness, Cross-functional leadership
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Drug safety, Regulatory compliance, Vendor governance, Clinical development
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Drug safety, Global safety operations, Vendor governance, Regulatory compliance
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Compliance strategy, Field commercialization, Risk management, Regulatory compliance, Stakeholder management
Redwood City, California, United States · Hybrid
$143k–$178k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Legal Technology Management, Contract Lifecycle Management, Matter Management, E-billing, Data Governance
Redwood City, California, United States · Hybrid
$273k–$321k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Machine learning, Drug discovery, Python, PyTorch, TensorFlow
Germany · Hybrid
$124k–$155k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Oncology sales, Team leadership, Strategic planning, Coaching, Market access
Germany · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Sales Leadership, Oncology Account Management, Strategic Account Planning, Team Coaching, Product Launch
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical supply chain, Pharmaceutical logistics, Inventory management, Cgmp, Packaging engineering
Redwood City, California, United States · Hybrid
$120k–$150k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: US GAAP, SOX, SEC reporting, Microsoft Office, Excel
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Statistical Programming, Oncology, Clinical Trials, SAS Programming, CDISC
Redwood City, California, United States · Hybrid
$120k–$150k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Laboratory automation, Tecan FluentControl, Hamilton Venus, Agilent VWorks, HighRes Cellario Scheduler
Munich, Bavaria, Germany · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Omnichannel strategy, Digital marketing, Customer engagement, Oncology, Data-driven marketing
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Safety science, Clinical trial protocols, Signal detection, Risk management
Japan · Remote OK
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical Development Strategy, Clinical Trial Management, Oncology Clinical Trials, Data Review, Protocol Authoring
Japan · Remote OK
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Biostatistics, Oncology Trial Design, Clinical Development Strategy, SAS, R
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
The Medical Science Liaison will execute field medical plans, engage in peer-to-peer scientific exchange with healthcare professionals, and gather medical insights within the UK territory. They will also support clinical study site engagement and collaborate cross-functionally with internal teams to advance the company's oncology pipeline.
Candidates must hold an advanced life science degree (PhD, MPharm, MD, or MSc) and possess over 8 years of relevant experience in Medical Affairs or clinical development. Strong expertise in oncology, particularly in lung and gastrointestinal cancers, along with excellent communication and networking skills, is required.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
We are seeking a highly motivated field medical professional to join our team as Medical Science Liaison, Oncology, UK. This role will execute approved field medical plans within an assigned UK territory, engage in peer-to-peer scientific exchange with healthcare professionals, gather and communicate medical insights, support clinical study site and investigator engagement, and contribute to medical education, advisory boards, and congress activities under the direction of the Medical Director, UK.
Medical Science Liaisons (MSLs) are an essential member of the Medical Affairs team who will work as an extension of the Medical Affairs organization. The MSL team will serve as a key liaison between Revolution Medicines and healthcare professionals. Within an assigned geographic territory, the MSL will be responsible for cultivating and strengthening professional relationships with key opinion leaders (KOLs), healthcare providers, and academic centers of excellence involved in various phases of product development. The individual will collaborate with stakeholders within medical affairs and across the organization, including but not limited to Clinical Development, Commercial, Program Management, Clinical Operations, and Compliance teams. The ideal candidate is an effective communicator, driven, detail-oriented, proactive, and a skilled collaborator.
The role is an individual contributor position with no direct line-management accountability.
The MSL contributes field insights and scientific expertise to support the Swiss medical plan but does not own country medical strategy, governance, budget, or team leadership.
Develop and maintain strong relationships with KOLs, healthcare professionals, and academic institutions to advance scientific and medical knowledge.
Communicate clinical and scientific data to KOLs and healthcare professionals through presentations, educational programs, and scientific discussions.
Collect, document, synthesise, and communicate field medical insights from KOLs and HCPs to the Medical Director and relevant internal teams.
Provide scientific support for medical congresses, advisory boards and other relevant scientific engagements to enhance the visibility of RevMed within the scientific and medical communities.
Establish credibility as a scientific expert and resource for internal stake holders, providing medical and scientific support for assigned products and therapeutic areas and territory.
Collaborate cross-functionally with Medical Affairs, Clinical Development, Commercial, Clinical Operations, and Compliance to support execution of approved medical strategies and tactics.
Stay current with scientific literature, emerging research, and competitive landscape.
Adhere to Revolution Medicines Core Values and policies.
Understand the regulatory requirements for customer engagement by field-based employees.
Develop and execute the field medical engagement plan for assigned accounts and stakeholders.
Maintain high-quality documentation of scientific interactions and insights in accordance with company systems and compliance requirements.
Support onboarding and informal coaching of new field medical colleagues, where appropriate.
Provide territory-level input to medical planning, launch readiness, and external engagement priorities.
Advanced life science degree (PhD, MPharm, MD os MSc).
8+ years of relevant experience in Medical Affairs, Field Medical, Clinical Development, or a similar role within the pharmaceutical or biotech industry; prior MSL experience in Switzerland strongly preferred.
Proven experience as an MSL or similar medical affairs role, ideally within oncology.
Strong understanding of clinical research methodologies and drug development processes.
Knowledge and experience within the oncology therapeutic area, preferred experience in lung and gastrointestinal cancers.
Excellent verbal and written communication skills
Proven ability to analyse and synthesize scientific information effectively.
Excellent presentation skills, with the ability to effectively communicate complex scientific data to diverse audiences.
Strong networking skills with proven ability to successfully build and maintain relationships with KOLs and healthcare professionals.
Self-directed and able to thrive in a fast-paced and dynamic environment.
Willingness to travel up to 60% of time.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
#LI-LO1 #LI-Remote
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution MedicineRevolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution Medicine